Medical NeuroScience Cluster Publications by
Dold Markus, Dr. :

2021 2020 2019 2018 2017 2016 2015 2013 2011

2021 Original Articles

• Bartova L, Dold M, Fugger G, Kautzky A, Mitschek M, Weidenauer A, Hienert M, Frey R, Mandelli L, Zohar J, Mendlewicz J, Souery D, Montgomery S, Fabbri C, Serretti A, Kasper S (2021) Sex‐related effects in major depressive disorder: Results of the European Group for the Study of Resistant Depression Depress Anxiety,
  | Weblink |
• Bartova L, Fugger G, Dold M, Swoboda M, Zohar J, Mendlewicz J, Souery D, Montgomery S, Fabbri C, Serretti A, Kasper S (2021) Combining psychopharmacotherapy and psychotherapy is not associated with better treatment outcome in major depressive disorder - evidence from the European Group for the Study of Resistant Depression J Psychiatr Res, 141: 167-175
  | Weblink |
• Dold M, Bartova L, Fugger G, Kautzky A, Mitschek M, Fabbri C, Montgomery S, Zohar J, Souery D, Mendlewicz J, Serretti A, Kasper S (2021) Melancholic features in major depression – a European multicenter study Prog Neuropsychopharmacol Biol Psychiatry, 110: 110285
  | Weblink |
• Bartova L, Dold M, Fugger G, Kautzky A, Mitschek M, Weidenauer A, Handschuh P, Frey R, Mandelli L, Zohar J, Mendlewicz J, Souery D, Montgomery S, Fabbri C, Serretti A, Kasper S (2021) The Role of Relationship Status in Major Depressive Disorder Results of the European Group for the Study of Resistant Depression J Affect Disord, 286: 149-157
  | Weblink |

2021 Reviews

• Kasper S, Erfurth A, Sachs G, Aichhorn W, Bartova L, Bengesser S, Buchmayer F, Deisenhammer E, Di Pauli J, Dold M, Falkai P, Frey R, Glück K, Hofer A, Holsboer-Trachsler E, Kautzky A, Konstantinidis A, Kraus C, Lehofer M, Marksteiner J, Mitschek M, Mörkl S, Oberlerchner H, Plener P, Psota G, Rados C, Rainer M, Schosser A, Seifritz E, Silberbauer C, Winkler D, Wunsch C, Zwanzger P (2021) Therapieresistente Depression: Diagnose und Behandlung, Konsensus-Statement Jatros Neurologie & Psychiatrie , Sonderheft 03/2021: 1-32

2020 Original Articles

• Dold M, Bartova L, Kasper S (2020) Treatment Response of Add-On Esketamine Nasal Spray in Resistant Major Depression in Relation to Add-On Second-Generation Antipsychotic Treatment Int J Neuropsychopharmacol, 23 (7): 440-445
  | Weblink |
• Fugger G, Dold M, Bartova L, Mitschek M, Souery D, Mendlewicz J, Serretti A, Zohar J, Montgomery S, Fabbri C, Frey R, Kasper S (2020) Clinical Correlates and Outcome of Major Depressive Disorder and Comorbid Migraine: A Report of the European Group for the Study of Resistant Depression Int J Neuropsychopharmacol, 23 (9): 571-577
  | Weblink |
• Kautzky A, Möller H, Dold M, Bartova L, Seemüller F, Laux G, Riedel M, Gaebel W, Kasper S (2020) Combining machine learning algorithms for prediction of antidepressant treatment response Acta Psychiatr Scand, 143 (1): 36-49
  | Weblink |
• Dold M, Bartova L, Fugger G, Mitschek M, Kautzky A, Frey R, Montgomery S, Zohar J, Mendlewicz J, Souery D, Fabbri C, Serretti A, Kasper S (2020) Add-on benzodiazepine treatment in patients with major depressive disorder – results from a European cross-sectional multicenter study Eur Neuropsychopharmacol, 41: 70-80
  | Weblink |

2020 Reviews

• Dold M, Kasper S (2020) Dose‐response relationship of selective serotonin reuptake inhibitors Acta Psychiatr Scand, 142 (6): 427-429
  | Weblink |

2019 Original Articles

• Pjrek E, Friedrich M, Cambioli L, Dold M, Jäger F, Komorowski A, Lanzenberger R, Kasper S, Winkler D (2019) The Efficacy of Light Therapy in the Treatment of Seasonal Affective Disorder: A Meta-Analysis of Randomized Controlled Trials Psychother Psychosom, 89 (1): 17-24
  | Weblink |
• Bartova L, Dold M, Kautzky A, Fabbri C, Spies M, Serretti A, Souery D, Mendlewicz J, Zohar J, Montgomery S, Schosser A, Kasper S (2019) Results of the European Group for the Study of Resistant Depression (GSRD) — basis for further research and clinical practice World J Biol Psychiatry, 20 (6): 427-448
  | Weblink |
• Fugger G, Dold M, Bartova L, Kautzky A, Souery D, Mendlewicz J, Serretti A, Zohar J, Montgomery S, Frey R, Kasper S (2019) Major depression and comorbid diabetes - Findings from the European Group for the Study of Resistant Depression Prog Neuropsychopharmacol Biol Psychiatry, 94: 109638
  | Weblink |
• Fugger G, Dold M, Bartova L, Kautzky A, Souery D, Mendlewicz J, Serretti A, Zohar J, Montgomery S, Frey R, Kasper S (2019) Comorbid hypertension in patients with major depressive disorder – Results from a European multicenter study Eur Neuropsychopharmacol, 29 (6): 777-785
  | Weblink |
• Dold M, Bartova L, Kautzky A, Porcelli S, Montgomery S, Zohar J, Mendlewicz J, Souery D, Serretti A, Kasper S (2019) Psychotic Features in Patients With Major Depressive Disorder J Clin Psychiatry, 80 (1): 17m12090
  | Weblink |
• Fabbri C, Kasper S, Kautzky A, Bartova L, Dold M, Zohar J, Souery D, Montgomery S, Albani D, Raimondi I, Dikeos D, Rujescu D, Uher R, Lewis C, Mendlewicz J, Serretti A (2019) Genome-wide association study of treatment-resistance in depression and meta-analysis of three independent samples Br J Psychiatry, 214 (1): 36-41
  | Weblink |
• Kautzky A, Dold M, Bartova L, Spies M, Kranz G, Souery D, Montgomery S, Mendlewicz J, Zohar J, Fabbri C, Serretti A, Lanzenberger R, Dikeos D, Rujescu D, Kasper S (2019) Clinical factors predicting treatment resistant depression: affirmative results from the European multicenter study Acta Psychiatr Scand, 139 (1): 78-88
  | Weblink |

2019 Book Chapters

• Kasper S, Bartova L, Dold M (2019) Psychopharmakotherapie der unipolaren Depression. . In: Bundesministerium für Arbeit, Soziales, Gesundheit und Konsumentenschutz., Depressionsbericht Österreich. Eine interdisziplinäre und multiperspektivische Bestandsaufnahme. Bundesministerium für Arbeit, Soziales, Gesundheit und Konsumentenschutz.: 170-182

2018 Original Articles

• Fugger G, Dold M, Bartova L, Kautzky A, Souery D, Mendlewicz J, Serretti A, Zohar J, Montgomery S, Frey R, Kasper S (2018) Comorbid thyroid disease in patients with major depressive disorder - results from the European Group for the Study of Resistant Depression (GSRD) Eur Neuropsychopharmacol, 28 (6): 752-760
  | Weblink |
• Dold M, Bartova L, Kautzky A, Serretti A, Porcelli S, Souery D, Mendlewicz J, Montgomery S, Zohar J, Kasper S (2018) Clinical factors associated with augmentation treatment with second-generation antipsychotics and lithium in major depression – Results from a European multicenter study Eur Neuropsychopharmacol, 28 (12): 1305-1313
  | Weblink |
• Bartova L, Papageorgiou K, Milenkovic I, Dold M, Weidenauer A, Willeit M, Winkler D, Kasper S (2018) Rapid antidepressant effect of S-ketamine in schizophrenia Eur Neuropsychopharmacol, 28 (8): 980-982
  | Weblink |
• Dold M, Bartova L, Fugger G, Kautzky A, Souery D, Mendlewicz J, Papadimitriou G, Dikeos D, Ferentinos P, Porcelli S, Serretti A, Zohar J, Montgomery S, Kasper S (2018) Major Depression and the Degree of Suicidality: Results of the European Group for the Study of Resistant Depression (GSRD) Int J Neuropsychopharmacol, 21 (6): 539-549
  | Weblink |
• Caraci F, Calabrese F, Molteni R, Bartova L, Dold M, Leggio G, Fabbri C, Mendlewicz J, Racagni G, Kasper S, Riva M, Drago F (2018) International Union of Basic and Clinical Pharmacology CIV: The Neurobiology of Treatment-resistant Depression: From Antidepressant Classifications to Novel Pharmacological Targets Pharmacol Rev, 70 (3): 475-504
  | Weblink |
• Fugger G, Dold M, Bartova L, Kautzky A, Souery D, Mendlewicz J, Serretti A, Zohar J, Montgomery S, Frey R, Kasper S (2018) Comorbid thyroid disease in patients with major depressive disorder - results from the European Group for the Study of Resistant Depression (GSRD) Eur Neuropsychopharmacol, 28 (6): 752-760
  | Weblink |
• Dold M, Bartova L, Mendlewicz J, Souery D, Serretti A, Porcelli S, Zohar J, Montgomery S, Kasper S (2018) Clinical correlates of augmentation/combination treatment strategies in major depressive disorder Acta Psychiatr Scand, 137 (5): 401-412
  | Weblink |
• Kautzky A, Dold M, Bartova L, Spies M, Vanicek T, Souery D, Montgomery S, Mendlewicz J, Zohar J, Fabbri C, Serretti A, Lanzenberger R, Kasper S (2018) Refining Prediction in Treatment-Resistant Depression J Clin Psychiatry, 79 (1): 16m11385
  | Weblink |
• Olgiati P, Serretti A, Souery D, Dold M, Kasper S, Montgomery S, Zohar J, Mendlewicz J (2018) Early improvement and response to antidepressant medications in adults with major depressive disorder. Meta-analysis and study of a sample with treatment-resistant depression J Affect Disord, 227: 777-786
  | Weblink |

2017 Original Articles

• Dold M, Bartova L, Souery D, Mendlewicz J, Porcelli S, Serretti A, Zohar J, Montgomery S, Kasper S (2017) Low comorbid obsessive-compulsive disorder in patients with major depressive disorder – Findings from a European multicenter study J Affect Disord, 227: 254-259
  | Weblink |
• Dold M, Bartova L, Rupprecht R, Kasper S (2017) Dose Escalation of Antidepressants in Unipolar Depression: A Meta-Analysis of Double-Blind, Randomized Controlled Trials Psychother Psychosom, : 283-291
  | Weblink |
• Dold M, Bartova L, Kautzky A, Souery D, Mendlewicz J, Serretti A, Porcelli S, Zohar J, Montgomery S, Kasper S (2017) The impact of comorbid post-traumatic stress disorder in patients with major depressive disorder on clinical features, pharmacological treatment strategies, and treatment outcomes – Results from a cross-sectional European multicenter study Eur Neuropsychopharmacol, 27 (7): 625-632
  | Weblink |
• Bartova L, Weidenauer A, Dold M, Naderi-Heiden A, Kasper S, Willeit M, Praschak-Rieder N (2017) Robust Antidepressant Effect Following Alternating Intravenous Racemic Ketamine and Electroconvulsive Therapy in Treatment-Resistant Depression J ECT, 33: e31-e32
  | Weblink |
• Dold M, Bartova L, Souery D, Mendlewicz J, Serretti A, Porcelli S, Zohar J, Montgomery S, Kasper S (2017) Clinical characteristics and treatment outcomes of patients with major depressive disorder and comorbid anxiety disorders - results from a European multicenter study J Psychiatr Res, 91: 1-13
  | Weblink |

2017 Book Chapters

• Kasper S, Dold M (2017) Mental disorders in primary care: A guide to their evaluation and management. In: Carvalho AF, McIntyre RS, Anxiety disorders in primary care Oxford University Press, Oxford: 90-98

2016 Original Articles

• Dold M, Kautzky A, Bartova L, Rabl U, Souery D, Mendlewicz J, Porcelli S, Serretti A, Zohar J, Montgomery S, Kasper S (2016) Pharmacological treatment strategies in unipolar depression in European tertiary psychiatric treatment centers – A pharmacoepidemiological cross-sectional multicenter study Eur Neuropsychopharmacol, 26 (12): 1960-1971
  | Weblink |
• Dold M, Kasper S (2016) Evidence-based pharmacotherapy of treatment-resistant unipolar depression Int J Psychiatry Clin Pract, 21: 13-23
  | Weblink |
• Dold M, Tardy M, Samara M, Li C, Kasper S, Leucht S (2016) Are all first-generation antipsychotics equally effective in treating schizophrenia? A meta-analysis of randomised, haloperidol-controlled trials World J Biol Psychiat, 17 (3): 210-220
  | Weblink |

2015 Original Articles

• Bartova L, Dold M, Praschak-Rieder N, Naderi-Heiden A, Kasper S (2015) Ultra-High-Dose Long-Acting Injectable Aripiprazole in Chronic Refractory Schizophrenia: A Case Report J Clin Toxicol, 05 (05)
• Dold M, Fugger G, Aigner M, Lanzenberger R, Kasper S (2015) Dose escalation of antipsychotic drugs in schizophrenia: A meta-analysis of randomized controlled trials Schizophr Res, 166 (1-3): 187-193
• Dold M, Aigner M, Lanzenberger R, Kasper S (2015) Antipsychotic augmentation of serotonin reuptake inhibitors in treatment-resistant obsessive-compulsive disorder: an update meta-analysis of double-blind, randomized, placebo-controlled trials Int J Neuropsychopharmacol,
• Dold M, Aigner M, Klabunde M, Treasure J, Kasper S (2015) Second-Generation Antipsychotic Drugs in Anorexia Nervosa: A Meta-Analysis of Randomized Controlled Trials Psychother Psychosom, 84: 110-116

2015 Reviews

• Kasper S, Dold M (2015) Factors contributing to the increasing placebo response in antidepressant trials World Psychiatry, 14 (3): 304-306
• Dold M, Kasper S (2015) Increasing placebo response in antipsychotic trials: a clinical perspective Evid Based Ment Health, 18 (3): 77-79

2013 Reviews

• Dold M, Aigner M, Lanzenberger R, Kasper S (2013) Antipsychotic augmentation of serotonin reuptake inhibitors in treatment-resistant obsessive-compulsive disorder: a meta-analysis of double-blind, randomized, placebo-controlled trials Int. J. Neuropsychopharmacol., 16 (3): 557-574

2011 Reviews

• Dold M, Aigner M, Lanzenberger R, Kasper S (2011) Effektivität einer Augmentationstherapie mit Antipsychotika bei therapieresistenten Zwangsstörungen – eine Metaanalyse doppelblinder, randomisierter, placebokontrollierter Studien Fortschr Neurol Psychiatr, 79 (08): 453-466